STS releases new guidelines for treating esophageal cancer
October 30, 2014 -- The Society of Thoracic Surgeons (STS) has released new clinical practice guidelines for treating cancer of the esophagus and gastroesophageal junction.
Study: Pretreatment pain intensity predicts survival for HNC patients
October 28, 2014 -- Pretreatment pain intensity is an independent survival predictor for patients with head and neck cancer (HNC), according to new research published in the Journal of Pain.
Henry Ford joins robotic cancer surgery clinical trial
October 27, 2014 -- The Henry Ford Hospital in Detroit has joined a U.S. clinical trial to study the effectiveness of a newer robotic cancer surgery in treating patients with advanced-stage oropharyngeal cancer.
Study: Cancer prognosis related to newly identified immune cells
October 24, 2014 -- A newly discovered type of immune cells in tumors is associated with less severe cancer outcomes in humans and may have therapeutic potential, according to a new study in the journal Cancer Cell. The better outcomes were especially strong in head and neck cancers and in breast cancers, the researchers found.
Study: Immune-related gene may predispose to HPV-related cancer
October 24, 2014 -- An international coalition of cancer specialists has identified an immune-related gene called transforming growth factor beta receptor 1 (TGFBR1) that appears to play a pivotal role in determining whether a person develops HPV-related cancer. Their findings are discussed in the journal Cancer Research.
Study: Potential link between breast cancer genes, salivary gland cancer
October 21, 2014 -- Researchers have found a potential link between mutations in the BRCA1 and BRCA2 breast cancer genes and salivary gland cancer, according to a new study in JAMA Otolaryngology -- Head & Neck Surgery.
Study: Scientists discover cancer-fighting berry in Australia
October 16, 2014 -- An experimental drug derived from berries from an Australian rainforest tree appears to kill head and neck tumors, as well as melanomas, according to the authors of a new study in PLoS One.
FDA approves expanded indications for Lymphoseek
October 16, 2014 -- The U.S. Food and Drug Administration (FDA) has approved expanded indications for Navidea Biopharmaceuticals' Lymphoseek radiopharmaceutical agent.
ADA 2014: Friday highlights
October 13, 2014 -- SAN ANTONIO - The American Dental Association (ADA) 2014 annual meeting continued on Friday, with a crowded exhibit floor, dozens of continuing education offerings, and the presentation of more 2014 Dental Excellence Awards. Here are a few highlights from Friday.
Dental Excellence Awards 2014 winners
October 9, 2014 -- is pleased to announce the winners of the 2014 Dental Excellence Awards, recognizing the very best in people, products, and services that are helping to improve the dental industry. Awards are being handed out at this year's ADA 2014 annual meeting in San Antonio.
Special Feature
Aspirin can help battle head/neck cancer

Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer. Read more.

Dentifrices and Consumer Products
Dry Mouth Products
Tools and Instruments
Oral Cancer Detection